Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Aesther Healthcare Acquisition (AEHA) Competitors

Aesther Healthcare Acquisition logo

AEHA vs. VINC, SYRS, ARDS, PBLA, SCPS, VRPX, TRVN, STAB, EVLO, and AMPE

Should you be buying Aesther Healthcare Acquisition stock or one of its competitors? The main competitors of Aesther Healthcare Acquisition include Vincerx Pharma (VINC), Syros Pharmaceuticals (SYRS), Aridis Pharmaceuticals (ARDS), Panbela Therapeutics (PBLA), Scopus BioPharma (SCPS), Virpax Pharmaceuticals (VRPX), Trevena (TRVN), Statera Biopharma (STAB), Evelo Biosciences (EVLO), and Ampio Pharmaceuticals (AMPE). These companies are all part of the "pharmaceutical preparations" industry.

Aesther Healthcare Acquisition vs. Its Competitors

Aesther Healthcare Acquisition (NASDAQ:AEHA) and Vincerx Pharma (NASDAQ:VINC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Aesther Healthcare Acquisition has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500. Comparatively, Vincerx Pharma has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500.

Aesther Healthcare Acquisition's return on equity of 0.00% beat Vincerx Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Aesther Healthcare AcquisitionN/A N/A N/A
Vincerx Pharma N/A -248.33%-132.73%

In the previous week, Aesther Healthcare Acquisition's average media sentiment score of 0.00 equaled Vincerx Pharma'saverage media sentiment score.

Company Overall Sentiment
Aesther Healthcare Acquisition Neutral
Vincerx Pharma Neutral

78.6% of Aesther Healthcare Acquisition shares are held by institutional investors. Comparatively, 44.0% of Vincerx Pharma shares are held by institutional investors. 19.8% of Aesther Healthcare Acquisition shares are held by company insiders. Comparatively, 15.6% of Vincerx Pharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aesther Healthcare AcquisitionN/AN/A-$560KN/AN/A
Vincerx PharmaN/AN/A-$40.16M-$20.600.00

Summary

Aesther Healthcare Acquisition beats Vincerx Pharma on 5 of the 6 factors compared between the two stocks.

Get Aesther Healthcare Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for AEHA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEHA vs. The Competition

MetricAesther Healthcare AcquisitionPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$91K$1.01B$6.04B$10.49B
Dividend YieldN/A4.84%5.73%4.80%
P/E RatioN/A1.2785.1927.32
Price / SalesN/A176.74516.16194.55
Price / CashN/A17.6437.5761.53
Price / Book-0.057.7812.426.81
Net Income-$560K-$7.59M$3.32B$276.59M

Aesther Healthcare Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEHA
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-99.9%$91KN/A0.002,021Gap Down
VINC
Vincerx Pharma
0.5264 of 5 stars
$0.05
flat
N/A-99.5%$266KN/A0.0060Gap Down
SYRS
Syros Pharmaceuticals
3.8221 of 5 stars
$0.01
flat
$1.00
+19,900.0%
-99.7%$134K$386K0.00120Gap Up
ARDS
Aridis Pharmaceuticals
N/A$0.00
+1,050.0%
N/AN/A$123KN/A0.0030Gap Down
High Trading Volume
PBLA
Panbela Therapeutics
0.0914 of 5 stars
$0.01
+0.9%
N/A-96.9%$54KN/A0.006
SCPS
Scopus BioPharma
N/A$0.00
flat
N/A+0.0%$42KN/A0.009
VRPX
Virpax Pharmaceuticals
0.0516 of 5 stars
$0.02
+90.9%
N/A-99.8%$26KN/A0.007Gap Up
TRVN
Trevena
1.6444 of 5 stars
$0.01
flat
$5.00
+41,566.7%
-99.4%$12K$443K0.0040Gap Up
STAB
Statera Biopharma
N/A$0.00
-50.0%
N/A-50.0%$5KN/A0.0020
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$4KN/A0.00120
AMPE
Ampio Pharmaceuticals
N/A$0.00
flat
N/A+22.7%$3KN/A0.0020

Related Companies and Tools


This page (NASDAQ:AEHA) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners